Laboratorios Richmond S.A.C.I.F.
RICH
Rank in Stocks
#21131
Laboratorios Richmond S.A.C.I.F. is a pharmaceutical firm focused on the... Laboratorios Richmond S.A.C.I.F. is a pharmaceutical firm focused on the development and production of a diverse range of medicinal products. Their extensive portfolio includes antiretroviral treatments for human immunodeficiency virus (HIV), as well as therapies for oncology and oncohematology conditions. The company also supplies various cardiometabolic medications, such as those for blood pressure reduction, cholesterol management, platelet aggregation inhibition, and blood sugar control. Additionally, they produce neurological and psychiatric drugs, covering analgesics, antipsychotics, antidepressants, anti-dementia agents, antiepileptics, hypnotics, and treatments for multiple sclerosis. These pharmaceutical offerings are distributed across Latin America, Africa, Asia, and the Middle East. Founded in 1935, Laboratorios Richmond S.A.C.I.F. is headquartered in Buenos Aires, Argentina.
Share Price
$0.90251515
Last synced: 2026-11-06
Market Cap
$72.88M
Change (1 day)
7.43%
Change (1 year)
-20.46%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Laboratorios Richmond S.A.C.I.F. (RICH)
Category
Healthcare
EPS for Laboratorios Richmond S.A.C.I.F. (RICH)
EPS as of June 2026 TTM: $0.10
According to Laboratorios Richmond S.A.C.I.F.'s latest financial reports, its current EPS (TTM) is $0.10. At the end of 2025 the company had an EPS of $0.03, a decrease compared to its 2024 EPS of $0.29.
EPS history for Laboratorios Richmond S.A.C.I.F. from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.10 | 241.00% |
| 2025 | $0.03 | -90.82% |
| 2024 | $0.29 | -272.84% |
| 2023 | $-0.17 | -564.15% |
| 2022 | $0.04 | -74.32% |
| 2021 | $0.14 | 28.58% |
| 2020 | $0.11 | 230.58% |
| 2019 | $0.03 | -129.89% |
| 2018 | $-0.11 | -336.29% |
| 2017 | $0.05 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 6,255.23% |
DE
|
|
| $6.08 | 5,840.96% |
DE
|
|
| $1.55 | 1,415.74% |
JP
|
|
| $3.66 | 3,477.71% |
CH
|
|
| $0.45 | 339.88% |
IL
|
Questions about Laboratorios Richmond S.A.C.I.F.'s earnings per share (EPS)
What is Laboratorios Richmond S.A.C.I.F.'s earnings per share (EPS)?
Laboratorios Richmond S.A.C.I.F.'s earnings per share (EPS) over the last twelve months is $0.10, as of Jun 2026.
What was Laboratorios Richmond S.A.C.I.F.'s earnings per share (EPS) in 2025?
In 2025, Laboratorios Richmond S.A.C.I.F.'s earnings per share (EPS) was $0.03, 89.66% less than in 2024 ($0.29).
How has Laboratorios Richmond S.A.C.I.F.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Laboratorios Richmond S.A.C.I.F.'s earnings per share (EPS) went from $0.11 to $0.03, an average decline of 22.88% a year.
How does Laboratorios Richmond S.A.C.I.F.'s earnings per share (EPS) compare with similar companies?
Laboratorios Richmond S.A.C.I.F.'s earnings per share (EPS) ($0.10) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.